Literature DB >> 22831273

Is the metabolic syndrome a "small baby" syndrome?: the bogalusa heart study.

Emily W Harville1, Sathanur Srinivasan, Wei Chen, Gerald S Berenson.   

Abstract

BACKGROUND: Metabolic syndrome has been called a "small baby syndrome," but other analyses suggest that postnatal growth is more important than birthweight, or that large babies are also at risk. The aim of this analysis was to examine whether there was a relationship between both low and high birthweight and metabolic syndrome, using multiple definitions of metabolic syndrome, and to determine whether this relationship varied by body size across the life course.
METHODS: Data from the Bogalusa Heart Study, a study of cardiovascular disease in children and young adults, were linked to birth certificate data. Metabolic syndrome was defined by the National Cholesterol Education Program, the International Diabetes Foundation, and the World Health Organization (WHO) definition. Small-for-gestational-age (SGA) was defined as birthweight <10(th) percentile by sex for gestational age and large-for-gestational-age (LGA) as birthweight >90(th) percentile. Birthweight-for-gestational-age was also examined as a continuous predictor. Chi-squared tests and logistic regression were used to examine the relationship between birth size and metabolic syndrome.
RESULTS: Higher birthweight-for-gestational-age was associated with a reduced risk of metabolic syndrome, especially by the WHO definition. After adjustment for body mass index (BMI), categorized birthweight was associated with metabolic syndrome, with the protective associations with LGA being stronger than the positive associations with SGA. Among the individual components of metabolic syndrome, higher waist circumference was associated with both SGA and LGA after BMI was controlled for. Effects of SGA and BMI at any age were largely independent rather than interactive.
CONCLUSIONS: SGA is associated with some, but not all, components of metabolic syndrome. The relationship between SGA and metabolic syndrome is partially confounded by later BMI.

Entities:  

Mesh:

Year:  2012        PMID: 22831273      PMCID: PMC3546360          DOI: 10.1089/met.2012.0031

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  41 in total

1.  Prediction of adult hypertension by K4 and K5 diastolic blood pressure in children: the Bogalusa Heart Study.

Authors:  A M Elkasabany; E M Urbina; S R Daniels; G S Berenson
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

2.  Intrauterine growth and adipose tissue development.

Authors:  G Enzi; V Zanardo; F Caretta; E M Inelmen; F Rubaltelli
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

3.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

Authors:  Michael P Stern; Ken Williams; Clicerio González-Villalpando; Kelly J Hunt; Steven M Haffner
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

4.  Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study.

Authors:  B Fagerberg; L Bondjers; P Nilsson
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

5.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

6.  Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study.

Authors:  M G Frontini; S R Srinivasan; G S Berenson
Journal:  Int J Obes Relat Metab Disord       Date:  2003-11

7.  Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.

Authors:  D J Barker; C N Hales; C H Fall; C Osmond; K Phipps; P M Clark
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

8.  Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study.

Authors:  D E Yarbrough; E Barrett-Connor; D Kritz-Silverstein; D L Wingard
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

9.  Substrate-energy metabolism and metabolic risk factors for cardiovascular disease in relation to fetal growth and adult body composition.

Authors:  Osama A Kensara; Steve A Wooton; David I W Phillips; Mayank Patel; Daniel J Hoffman; Alan A Jackson; Marinos Elia
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03-10       Impact factor: 4.310

10.  Low birth weight and longitudinal trends of cardiovascular risk factor variables from childhood to adolescence: the bogalusa heart study.

Authors:  Maria G Frontini; Sathanur R Srinivasan; Jihua Xu; Gerald S Berenson
Journal:  BMC Pediatr       Date:  2004-11-03       Impact factor: 2.125

View more
  8 in total

Review 1.  The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.

Authors:  Wenhua Jiang; Manling Liu; Chunhu Gu; Heng Ma
Journal:  Cardiovasc Toxicol       Date:  2020-10-01       Impact factor: 3.231

Review 2.  Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction.

Authors:  Vladislava Zohdi; Kyungjoon Lim; James T Pearson; M Jane Black
Journal:  Nutrients       Date:  2014-12-29       Impact factor: 5.717

3.  Low Birth Weight as a Predictor of Cardiovascular Risk Factors in Childhood and Adolescence? The PEP Family Heart Study.

Authors:  Gerda-Maria Haas; Evelyn Liepold; Peter Schwandt
Journal:  Int J Prev Med       Date:  2015-12-21

Review 4.  Exosomes and miRNA-Loaded Biomimetic Nanovehicles, a Focus on Their Potentials Preventing Type-2 Diabetes Linked to Metabolic Syndrome.

Authors:  Diane Beuzelin; Bertrand Kaeffer
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

5.  Oral Delivery of miRNA With Lipidic Aminoglycoside Derivatives in the Breastfed Rat.

Authors:  Diane Beuzelin; Bruno Pitard; Bertrand Kaeffer
Journal:  Front Physiol       Date:  2019-08-13       Impact factor: 4.566

6.  Extreme Birth Weight and Metabolic Syndrome in Children.

Authors:  Teofana Otilia Bizerea-Moga; Laura Pitulice; Cristina Loredana Pantea; Orsolya Olah; Otilia Marginean; Tudor Voicu Moga
Journal:  Nutrients       Date:  2022-01-02       Impact factor: 5.717

7.  Lifetime cardiovascular risk factors and maternal and offspring birth outcomes: Bogalusa Babies.

Authors:  Emily W Harville; Maeve E Wallace; Hua He; Lydia A Bazzano
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

Review 8.  Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.

Authors:  Helen H Wang; Dong Ki Lee; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.